What is the recommended treatment for a breast papilloma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Breast Papilloma Treatment

Surgical excision is recommended for all breast papillary lesions due to the significant risk of upgrade to malignancy (up to 21.4%) and the inability to reliably distinguish benign from malignant lesions on imaging or core biopsy alone. 1, 2

Initial Diagnostic Approach

When a breast papilloma is suspected or diagnosed on core needle biopsy, the following evaluation is mandatory:

  • Obtain bilateral diagnostic mammography as the initial imaging study 1
  • Perform targeted ultrasound of the affected breast, as it is more sensitive than mammography for detecting papillary lesions 1
  • Core needle biopsy (CNB) is preferred over fine needle aspiration for tissue diagnosis prior to any surgical procedure 1

Management Based on Core Biopsy Results

Benign Papilloma on Core Biopsy

Surgical excision should still be performed despite a benign diagnosis on core biopsy 1, 3, 4. The rationale includes:

  • The upgrade rate to malignancy ranges from 0-21.4% even when core biopsy shows benign papilloma 5, 2
  • Imaging features cannot reliably differentiate benign from malignant papillary lesions 3
  • Complete histopathological examination of the entire lesion is necessary to rule out focal atypia or carcinoma 4

Exception: Some recent evidence suggests that surgical excision may not be required for benign papillomas diagnosed on 11-gauge vacuum-assisted breast biopsy (upgrade rate 0%), but this remains controversial and excision is still generally recommended 5

Atypical Papilloma on Core Biopsy

Immediate surgical excision is mandatory 1, 5. Key considerations:

  • Upgrade rate to malignancy is 18.2% for atypical papillomas 5
  • These lesions fall into the B3 category (lesion of uncertain malignant potential) requiring excision 6
  • The presence of atypia on core biopsy is significantly associated with malignancy at final excision (P = 0.031) 5

Papillary Lesions with DCIS, LCIS, or Other High-Risk Features

Surgical excision is required with the following specifications 1:

  • Ensure negative margins on all resected tissue
  • If margins are positive or close, re-excision is necessary
  • Consider risk-reduction therapy according to breast cancer risk reduction guidelines 1
  • Maintain regular breast cancer screening following treatment 1

Surgical Technique

The surgical approach should prioritize complete excision while preserving cosmesis:

  • Use curvilinear skin incisions following Langer's lines for optimal cosmetic results 1
  • Excise the lesion with a rim of grossly normal tissue without excessive sacrifice of breast tissue 1
  • Close skin with subcuticular technique to minimize visible scarring 1
  • Preserve subcutaneous tissue with separate closure to improve cosmetic outcome 1
  • For non-palpable lesions, perform needle localization under ultrasound guidance prior to excision 2

Post-Excision Management

If Final Pathology Shows Benign Papilloma

  • Return to routine breast cancer screening 1
  • No additional follow-up is required beyond standard screening, as solitary benign papillomas do not significantly increase cancer risk 4

If Final Pathology Shows Atypical Hyperplasia or LCIS

  • Consider risk-reduction therapy per breast cancer risk reduction guidelines 1
  • Counsel patient to maintain regular breast screening with annual mammography 1
  • For multiple papillomas, annual surveillance with digital mammography is recommended due to increased cancer risk 4

If Final Pathology Shows Malignancy

  • Treat according to breast cancer treatment guidelines based on stage and tumor characteristics 1
  • Ensure adequate margins were achieved; if not, re-excision or mastectomy may be required 1

Common Pitfalls to Avoid

  • Do not rely on imaging alone to determine benignity—tissue diagnosis is essential 3
  • Do not assume concordance between core biopsy and final pathology—upgrade rates are significant even for "benign" papillomas 5, 2
  • Do not perform frozen section examination on papillary lesions, as distinguishing atypical hyperplasia from DCIS is impossible on frozen sections 1
  • Do not observe papillary lesions without excision, even if they appear benign on imaging and core biopsy 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Breast papillary lesions: an analysis of 70 cases.

Ecancermedicalscience, 2014

Research

Papillary lesions of the breast: imaging findings and diagnostic challenges.

Diagnostic and interventional radiology (Ankara, Turkey), 2013

Research

Papillary lesions of the breast.

Virchows Archiv : an international journal of pathology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.